Haemonetics | HAE - Gross Profit On Sales

Stock Price
60.52
Daily Change
0.96 1.61%
Monthly
-5.78%
Yearly
-0.84%
Q2 Forecast
55.12

Haemonetics reported $202.39M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Avanos Medical USD 86M 0 Dec/2025
Baxter International USD 577M 373M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Boston Scientific USD 3.68B 136M Dec/2025
Cerus USD 33.33M 8.66M Dec/2024
Cooper Companies USD 695.2M 44.4M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.39B 147M Dec/2025
Globus Medical USD 535.95M 49.28M Dec/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
ICU Medical USD 202.98M 2.1M Dec/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
Masimo USD 247.3M 16.7M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Merit Medical Systems USD 195.35M 8.94M Dec/2025
Neogen USD 106.7M 11.73M Sep/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Quidel USD 274.8M 1.01B Dec/2025
ResMed USD 878.72M 57.9M Dec/2025
STAAR Surgical USD 43.74M 34.13M Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Surmodics USD 20.08M 31.62M Jun/2025
Teleflex USD 307.45M 144.2M Dec/2025
Terumo JPY 153.19B 6.2B Dec/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
US Physical Therapy USD 40.13M 3.26M Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025